The number of IVT injections in the US continued to climb, as Avastin’s share declined somewhat and Lucentis’ share increased.
The Association of Research in Vision and Ophthalmology (ARVO) offered a window on cutting edge eye science and medicine plus clinical trials updates for retinal agents.
CATT, Lucentis & Avastin
Other AMD & DME Clinical Trials
Investigational Glaucoma Therapies
Genetics & Genomics
Nanotechnology & Regenerative Medicine
A number of scientific posters explored investigational glaucoma therapeutics.
Practice Scope is Market Scope’s new online survey application designed to bring more value to survey participants, improve response rates, and ultimately improve the scope and precision of our reports on the ophthalmic market.
Our new 2011 Comprehensive Report on the Global IOL Market forecasts significant revenue growth in the next five years.
This month's news includes the latest from Alcon, Novartis, WaveTec Vision Systems, Merck, Inspire Pharmaceuticals, iCo Therapeutics, Akorn, and Advanced Vision Research.
You are not currently logged in.
©2017 Market Scope
Lost your Password